Conflicting effects of atazanavir therapy on atherosclerotic risk factors in stable HIV patients: A randomized trial of regimen switch to atazanavir.
Joshua A BeckmanBrian R WoodKevin L ArdChristin N PriceDaniel A SolomonJonah P ZuflachtJessica MilianJoshua C PrennerPaul E SaxPublished in: PloS one (2017)
ClinicalTrials.gov NCT03019783.